Thoracic Cancer

Cancer collection based on different tumor types
8 August 2022
20 February 2023
Export Citation(s)Download PDF(s)

Thoracic Cancer

Open Access

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience

Qian Zhao,  Feng Li,  Ping Song,  Xiaogang Zhou,  Zhiming An,  Jiangang Mei,  Jingjing Shao,  Hanqing Li,  Xuli Wang,  Xing Guo,  Yongping Zhai, 
Open Access

Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases

Zhixue Fu,  Xu Yang,  Nan Bi,  Yirui Zhai,  Dongfu Chen,  Wenqing Wang,  Lei Deng,  Tao Zhang,  Zongmei Zhou,  Jun Liang, 
Open Access

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

Jing-Bo Wang,  Xue Huang,  Fu-Rong Li, 
Open Access

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy

Ming Zhou,  Xiaoyuan Chen,  Hong Zhang,  Lin Xia,  Xin Tong,  Limin Zou,  Ruimin Hao,  Jianhong Pan,  Xiao Zhao,  Dongmei Chen,  Yuanyuan Song,  Yueli Qi,  Ling Tang,  Zhifang Liu,  Rong Gao,  Yuankai Shi,  Zhimin Yang, 
Open Access

Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer

Romano Demicheli,  Marco Fornili,  Patrizia Querzoli,  Massimo Pedriali,  Saverio Alberti,  Christine Desmedt,  Elia Biganzoli, 
Open Access

Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?

Yaxiong Zhang,  Lianpeng Chang,  Wenfeng Fang,  Yunpeng Yang,  Lanjun Zhang,  Shaodong Hong,  Huaqiang Zhou,  Yanfang Guan,  Xin Yi,  Li Zhang, 
Open Access

PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer

Trine Vilsbøll Larsen,  Dianna Hussmann,  Anders Lade Nielsen, 
Open Access

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

Ji-Yeon Kim,  Seri Park,  Seock-Ah Im,  Sung-Bae Kim,  Joohyuk Sohn,  Keun Seok Lee,  Yee Soo Chae,  Ki Hyeong Lee,  Jee Hyun Kim,  Young-Hyuck Im,  Tae-Yong Kim,  Kyung-Hun Lee,  Jin-Hee Ahn,  Gun Min Kim,  In Hae Park,  Soo Jung Lee,  Hye Sook Han,  Se Hyun Kim,  Kyung Hae Jung,  Yeon Hee Park,  Korean Cancer Study Group , 
Open Access

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?

Jin Wang,  Hailin Tang,  Xing Li,  Cailu Song,  Zhenchong Xiong,  Xi Wang,  Xiaoming Xie,  Jun Tang, 
Open Access

Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer

Jie Zhang,  Chen Tian,  Fang Lv,  Jianfei Wang,  Wenbo Han,  Jun Nie,  Ling Dai,  Weiheng Hu,  Xiaoling Chen,  Xiangjuan Ma,  Guangming Tian,  Di Wu,  Sen Han,  Yang Wang,  Jieran Long,  Ziran Zhang,  Jian Fang,  Henghui Zhang, 
Open Access

Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis

Xin You,  Weiye Jiang,  Wenhua Lu,  Hui Zhang,  Tiantian Yu,  Jingyu Tian,  Shijun Wen,  Guillermo Garcia-Manero,  Peng Huang,  Yumin Hu, 
Open Access

Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial

Jing Huang,  Binghe Xu,  Ying Liu,  Junxing Huang,  Ping Lu,  Yi Ba,  Lin Wu,  Yuxian Bai,  Shu Zhang,  Jifeng Feng,  Ying Cheng,  Jie Li,  Lu Wen,  Xianglin Yuan,  Changwu Ma,  Chunhong Hu,  Qingxia Fan,  Xi Wang, 
Open Access

Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations

Fang Wang,  Xia-Yao Diao,  Xiao Zhang,  Qiong Shao,  Yan-Fen Feng,  Xin An,  Hai-Yun Wang, 
Open Access

A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia

Jie Luo,  Lee F. Langer,  Jian Liu, 
Open Access

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

Xiuwen Guan,  Fei Ma,  Chunxiao Li,  Shiyang Wu,  Shangying Hu,  Jiefen Huang,  Xiaoying Sun,  Jiayu Wang,  Yang Luo,  Ruigang Cai,  Ying Fan,  Qiao Li,  Shanshan Chen,  Pin Zhang,  Qing Li,  Binghe Xu, 
Open Access

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study

Binliang Liu,  Tao An,  Meiying Li,  Zongbi Yi,  Chunxiao Li,  Xiaoying Sun,  Xiuwen Guan,  Lixi Li,  Yanfeng Wang,  Yuhui Zhang,  Binghe Xu,  Fei Ma,  Yixin Zeng, 
Open Access

Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells

Lei Zhou,  Dandan Sheng,  Qiaodan Deng,  Dong Wang,  Suling Liu, 
Open Access

Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells

Mengying Tong,  Ziqian Deng,  Mengying Yang,  Chang Xu,  Xiaolong Zhang,  Qingzheng Zhang,  Yuwei Liao,  Xiaodi Deng,  Dekang Lv,  Xuehong Zhang,  Yu Zhang,  Peiying Li,  Luyao Song,  Bicheng Wang,  Aisha Al-Dherasi,  Zhiguang Li,  Quentin Liu, 
Open Access

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4

Liru He,  Haixia Deng,  Shiliang Liu,  Jiewei Chen,  Binkui Li,  Chenyuan Wang,  Xin Wang,  Yiguo Jiang,  Ningfang Ma,  Mengzhong Liu,  Dan Xie, 
Open Access

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution's clinical practice experience

Xiangyang Yu,  Xuewen Zhang,  Zichen Zhang,  Yongbin Lin,  Yingsheng Wen,  Yongqiang Chen,  Weidong Wang,  Lanjun Zhang, 

Other Thoracic Cancer articles

In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
Liling Zhu, Shunrong Li, Luyuan Tan, Xiaolan Zhang, Jiannan Wu, Fengxi Su, Kai Chen, Erwei Song
Published: 04 December 2019


The immune landscape of esophageal cancer
Tu-Xiong Huang, Li Fu
Published: 26 November 2019


Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone, Kazuo Kasahara
Published: 21 November 2019


The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao
Published: 07 November 2019